Boyar Asset Management Inc. Raises Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Boyar Asset Management Inc. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.8% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 5,304 shares of the company’s stock after buying an additional 986 shares during the quarter. Boyar Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $413,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Wynn Capital LLC raised its stake in GE HealthCare Technologies by 4.1% in the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock valued at $284,000 after buying an additional 122 shares in the last quarter. Fiduciary Trust Co boosted its holdings in GE HealthCare Technologies by 1.8% in the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after purchasing an additional 133 shares in the last quarter. Quent Capital LLC increased its stake in GE HealthCare Technologies by 21.3% in the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock valued at $71,000 after purchasing an additional 137 shares during the last quarter. Tempus Wealth Planning LLC increased its stake in GE HealthCare Technologies by 0.5% in the second quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock valued at $2,407,000 after purchasing an additional 141 shares during the last quarter. Finally, Little House Capital LLC lifted its position in shares of GE HealthCare Technologies by 1.8% during the 2nd quarter. Little House Capital LLC now owns 8,074 shares of the company’s stock worth $629,000 after buying an additional 141 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently commented on GEHC. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price on the stock. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, The Goldman Sachs Group began coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $85.09 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The stock’s 50 day moving average is $82.09 and its two-hundred day moving average is $83.52. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The firm has a market capitalization of $38.84 billion, a PE ratio of 24.88, a P/E/G ratio of 3.17 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The firm had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. GE HealthCare Technologies’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.92 earnings per share. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.